Skip to main content
TipRanks
Go Ultimate75% OFF

Daniel Kazado Insider Profile

4 Followers

Daniel Kazado, former Director at Immune Pharmaceuticals, holds 240.62K shares in Immune Pharmaceuticals (Ticker: IMNPQ). Most recently, Daniel Kazado Bought 76,503 shares of Immune Pharmaceuticals on Jan 04, 2017 for an estimated value of $13.77K.

Daniel Kazado's Trading History

IMNPQ
Immune Pharmaceuticals
Jan 04, 2017―Informative Buy13.77K$2.41K
IMNPQ
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jan 04, 2017Informative Buy$13.77K76,503$0.18-84.30%
Dec 20, 2016Informative Buy$29.05K161,377$0.18-85.90%
Aug 04, 2016Informative Buy$300.00K666,667$0.45-76.50%
Dec 08, 2015Informative Buy$117.00K150,000$0.78-74.40%
Sep 16, 2015Informative Buy$73.00K50,000$1.46-79.50%

You May Also Like

Daniel Kazado insider profile FAQ

What is the percentage of profitable transactions made by Daniel Kazado?
The percentage of profitable transactions made by Daniel Kazado is 0%.
What is the average return per transaction made by Daniel Kazado?
The average return per transaction made by Daniel Kazado is -77.50%.
What stocks does Daniel Kazado hold?
Daniel Kazado holds: IMNPQ stocks.
What was Daniel Kazado’s latest transaction?
Daniel Kazado’s latest transaction was an Informative Buy of $13.77K.
What was Daniel Kazado's most profitable transaction?
Daniel Kazado’s most profitable transaction was an Informative Buy of IMNPQ stock on December 3, 2014. The return on the trade was -66.20%.
What is Daniel Kazado's role in Immune Pharmaceuticals?
Daniel Kazado's role in Immune Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.